Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Neoplasms of the CNS

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 27 articles: HTML format

Single Articles

April 2025
1. FRANCA VELO A, Giantini Larsen A, Humm JL, Zanzonico P, et al
   Determination of the Intralesional Distribution of Theranostic (124)I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma.
   J Nucl Med. 2025 Apr 30:jnumed.124.267995. doi: 10.2967/jnumed.124.267995.
   PubMed     Abstract available
   
   
   
2. BARRY N, Kendrick J, Rowshanfarzad P, Hassan GM, et al
   An External, Independent Validation of an O-(2-[(18)F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma.
   J Nucl Med. 2025 Apr 3:jnumed.124.268925. doi: 10.2967/jnumed.124.268925.
   PubMed     Abstract available
   
   
   March 2025
3. IMBER BS, Yu KKH, Abida W, Pike LRG, et al
   Symptomatic Prostate-Specific Membrane Antigen PET-Positive Radionecrosis After Multimodality Brain Metastasis-Directed Treatment Including [(177)Lu]Lu-PSMA-617.
   J Nucl Med. 2025 Mar 6:jnumed.124.269175. doi: 10.2967/jnumed.124.269175.
   PubMed    
   
   
   January 2025
4. LANGEN KJ, Stoffels G, Filss CP, Kocher M, et al
   Borderline Findings in O-(2-[(18)F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice.
   J Nucl Med. 2025 Jan 16:jnumed.124.268768. doi: 10.2967/jnumed.124.268768.
   PubMed     Abstract available
   
   
   November 2024
5. ERMIS E, Bachmann N, Lutz K, Pyka T, et al
   Meningioma Revisited: Should Whole-Body Staging with [(68)Ga]Ga-DOTATOC PET/CT of High-Grade Meningiomas Become Standard Practice?
   J Nucl Med. 2024 Nov 21:jnumed.124.267934. doi: 10.2967/jnumed.124.267934.
   PubMed    
   
   
   October 2024
6. AMEREIN A, Maurer C, Kircher M, Gable A, et al
   Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy.
   J Nucl Med. 2024 Oct 24:jnumed.124.268217. doi: 10.2967/jnumed.124.268217.
   PubMed     Abstract available
   
   
   
7. ALBERT NL, Preusser M, Galldiks N, Ivanidze J, et al
   Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands.
   J Nucl Med. 2024 Oct 10:jnumed.124.268314. doi: 10.2967/jnumed.124.268314.
   PubMed    
   
   
   August 2024
8. PANDIT-TASKAR N, Zanzonico PB, Grkovski M, Donzelli M, et al
   Theranostic Intratumoral Convection-Enhanced Delivery of (124)I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.
   J Nucl Med. 2024 Aug 14:jnumed.123.266365. doi: 10.2967/jnumed.123.266365.
   PubMed     Abstract available
   
   
   
9. SEVERI S, Grassi I, Bongiovanni A, Nicolini S, et al
   Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.
   J Nucl Med. 2024 Aug 14:jnumed.123.266956. doi: 10.2967/jnumed.123.266956.
   PubMed     Abstract available
   
   
   July 2024
10. WICHMANN CW, Morgan KA, Cao Z, Osellame LD, et al
    Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of (225)Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.
    J Nucl Med. 2024 Jul 25:jnumed.123.266894. doi: 10.2967/jnumed.123.266894.
    PubMed     Abstract available
    
    
    
11. OSTER C, Kessler L, Blau T, Keyvani K, et al
    The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, (68)Ga-FAPI-46 PET Data, and Survival Data.
    J Nucl Med. 2024 Jul 3:jnumed.123.267151. doi: 10.2967/jnumed.123.267151.
    PubMed     Abstract available
    
    
    April 2024
12. ROSEN J, Werner JM, Ceccon GS, Rosen EK, et al
    MRI and (18)F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis.
    J Nucl Med. 2024 Apr 25:jnumed.123.266687. doi: 10.2967/jnumed.123.266687.
    PubMed     Abstract available
    
    
    March 2024
13. PRUIS IJ, Verburg FA, Balvers RK, Harteveld AA, et al
    [(18)F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors.
    J Nucl Med. 2024 Mar 21:jnumed.123.266853. doi: 10.2967/jnumed.123.266853.
    PubMed     Abstract available
    
    
    February 2024
14. EIGLER C, McDougall L, Bauman A, Bernhardt P, et al
    Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
    J Nucl Med. 2024 Feb 29:jnumed.123.266817. doi: 10.2967/jnumed.123.266817.
    PubMed     Abstract available
    
    
    
15. LOHMANN P, Gutsche R, Werner JM, Shah NJ, et al
    Example of Artificial Intelligence-Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management.
    J Nucl Med. 2024 Feb 15:jnumed.123.267112. doi: 10.2967/jnumed.123.267112.
    PubMed    
    
    
    
16. TOLBOOM N, Verger A, Albert NL, Fraioli F, et al
    Theranostics in Neurooncology: Heading Toward New Horizons.
    J Nucl Med. 2024;65:167-173.
    PubMed     Abstract available
    
    
    October 2023
17. MAULER J, Lohmann P, Maudsley AA, Sheriff S, et al
    Diagnostic Accuracy of MR Spectroscopic Imaging and (18)F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study.
    J Nucl Med. 2023 Oct 26:jnumed.123.265868. doi: 10.2967/jnumed.123.265868.
    PubMed     Abstract available
    
    
    September 2023
18. HABERBOSCH L, Gillett D, MacFarlane J, Koulouri O, et al
    Dual Role for l-[Methyl-(11)C]-Methionine PET in Acromegaly: Confirming Remission and Detecting Recurrence.
    J Nucl Med. 2023 Sep 28:jnumed.123.266446. doi: 10.2967/jnumed.123.266446.
    PubMed    
    
    
    August 2023
19. LOHMEIER J, Radbruch H, Brenner W, Hamm B, et al
    Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using (18)F-FET PET.
    J Nucl Med. 2023 Aug 31:jnumed.123.265642. doi: 10.2967/jnumed.123.265642.
    PubMed     Abstract available
    
    
    
20. VAN LITH SAM, Pruis IJ, Tolboom N, Snijders TJ, et al
    PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.
    J Nucl Med. 2023 Aug 31:jnumed.123.265738. doi: 10.2967/jnumed.123.265738.
    PubMed     Abstract available
    
    
    
21. GUTSCHE R, Lowis C, Ziemons K, Kocher M, et al
    Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.
    J Nucl Med. 2023 Aug 10:jnumed.123.265725. doi: 10.2967/jnumed.123.265725.
    PubMed     Abstract available
    
    
    
22. ALBERT NL, Nelwan DV, Fleischmann DF, Quach S, et al
    Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma.
    J Nucl Med. 2023 Aug 3:jnumed.122.265247. doi: 10.2967/jnumed.122.265247.
    PubMed     Abstract available
    
    
    June 2023
23. MILOSEVIC A, Styczen H, Grueneisen J, Li Y, et al
    Evaluation of [(68)Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space.
    J Nucl Med. 2023 Jun 29:jnumed.123.265424. doi: 10.2967/jnumed.123.265424.
    PubMed     Abstract available
    
    
    May 2023
24. GALLDIKS N, Langen KJ
    Hybrid (18)F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors.
    J Nucl Med. 2023 May 18:265647. doi: 10.2967/jnumed.123.265647.
    PubMed    
    
    
    April 2023
25. GRAEF J, Bluemel S, Brenner W, Amthauer H, et al
    [(177)Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement.
    J Nucl Med. 2023 Apr 28:jnumed.122.264850. doi: 10.2967/jnumed.122.264850.
    PubMed     Abstract available
    
    
    
26. SMITH NJ, Deaton TK, Territo W, Graner B, et al
    Hybrid (18)F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases.
    J Nucl Med. 2023 Apr 28:jnumed.122.265149. doi: 10.2967/jnumed.122.265149.
    PubMed     Abstract available
    
    
    
27. GALLDIKS N, Lohmann P, Fink GR, Langen KJ, et al
    Amino Acid PET in Neurooncology.
    J Nucl Med. 2023 Apr 13:264859. doi: 10.2967/jnumed.122.264859.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.